2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2025 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
James Knight, MD, discusses the potential launch of a case series of patients with brain-metastatic prostate adenocarcinoma.
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
James Knight, MD, resident, Radiation Medicine, the University of Kentucky College of Medicine, discusses the potential launch of a case series of patients with brain-metastatic prostate adenocarcinoma, highlighting the importance of the continued research regarding additional biomarkers which may improve the treatment landscape.
Related Content: